Chronic Disease Management Startup Curie Ai Secures Seed Funding From Resmed To Advance Respiratory Illness Evaluation And Care
Chronic Disease Management Startup Curie Ai Secures Seed Funding From Resmed To Advance Respiratory Illness Evaluation And Care
04/12/22, 12:00 PM
Location
Round Type
seed
Curie AI, a tech-enabled respiratory care company that has developed cutting-edge technology for passive respiratory patient monitoring, today announced the closing of a seed round from investors that include ResMed, Factory and SeedToB.
Company Info
Location
santa clara, california, united states
Additional Info
Curie AI is a StartX-backed tech-enabled respiratory care provider that makes it easy to provide virtual personalized disease management and life-saving care using patented AI technology, actionable insights, and a specialized clinical team. Our passive monitoring technology allows for automatic adherence resulting in early detection by our smart care team and a reduction in adverse events — saving costs and improving quality of life. Learn more at www.curieai.com.